If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
1
Followers on Owler
Catbio
's headquarters is located in South San Francisco, California. Catbio generates $227.5K in revenue per employee Catbio has 1 followers on Owler.
Overview
News & Insights
Catbio
's headquarters is located in South San Francisco, California. Catbio generates $227.5K in revenue per employee Catbio has 1 followers on Owler.
CEO
Add
CEO Approval Rating
- -/100
1997
South San Francisco
California
Private
Health Care Equipment & Services
Add Sector
http://www.catbio.com
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
News
Latest News
Jun 01, 2022
Global Legal Chronicle
Catbio: Catalyst Biosciences' $60 Million Sale of Complement Portfolio
May 23, 2022
GlobeNewswire
Press Release: Catbio : Catalyst Biosciences Sells Complement Portfolio for $60 Million
Jul 22, 2021
GlobalNewswire
Press Release: Catbio : Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies
Nov 03, 2020
GlobeNewswire
Press Release: Catbio : Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference
Dec 09, 2019
GlobeNewswire
Press Release: Catbio : Catalyst Biosciences Presents Two Posters on MarzAA at the 61st Annual American Society of Hematology Conference
Apr 01, 2019
StreetInsider
Press Release: Catbio : Catalyst Biosciences Receives Orphan Designation from the European Commission for Marzeptacog Alfa (Activated)
Dec 01, 2018
GlobalNewswire
Press Release: Catbio : Catalyst Biosciences Announces Updated Positive Interim Data from Its Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
Feb 13, 2018
econotimes
Press Release: Catalyst Biosciences : Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
Jan 31, 2018
StreetInsider
Catalyst Biosciences: Catalyst Biosciences to Present Multi-Dose Subcutaneous Data for CB 2679d in Individuals with Hemophilia B in an Oral Presentation at the 11th Annual Congress of EAHAD
Dec 20, 2017
StreetInsider
Press Release: Catalyst Biosciences : Catalyst Biosciences Announces Proposed Public Offering of Common Stock
Follow and Get Alerts